Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Fanconi Anemia
NCT03398824Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in Fanconi anemia (FA), sponsored by Boston Children's Hospital. Primary endpoint: Hematologic Response at 6 months. Started Mar 2018; status: completed.
02
Drugs
metformin
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT03398824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03398824.